isoproterenol has been researched along with Cardiac Rupture, Traumatic in 56 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "6-Shogaol pretreatment decreased the activities of cardiac and lipid peroxidative markers and enhanced the antioxidant status in ISO-induced cardiac injury rats." | 5.72 | 6-Shogaol protects against isoproterenol-induced cardiac injury in rats through attenutating oxidative stress, inflammation, apoptosis and activating nuclear respiratory factor-2/heme oxygenase-1 signaling pathway. ( Hu, L; Li, H; Luo, W; Shen, J; Zhang, Y, 2022) |
| " Isoproterenol (ISO)-induced cardiotoxicity challenged mice were treated with NY for 28 days at two doses (0." | 3.88 | Nanoyttria attenuates isoproterenol-induced cardiac injury. ( Godugu, C; Khurana, A; Kumari, P, 2018) |
| "01) in either 11 control or 10 animals injected with isoproterenol and experiencing transient hypotension." | 3.66 | Cardiovascular injury from blunt thoracic impact of epinephrine and isoproterenol injected rabbits. ( Viano, DC, 1983) |
| "6-Shogaol pretreatment decreased the activities of cardiac and lipid peroxidative markers and enhanced the antioxidant status in ISO-induced cardiac injury rats." | 1.72 | 6-Shogaol protects against isoproterenol-induced cardiac injury in rats through attenutating oxidative stress, inflammation, apoptosis and activating nuclear respiratory factor-2/heme oxygenase-1 signaling pathway. ( Hu, L; Li, H; Luo, W; Shen, J; Zhang, Y, 2022) |
| " However, it is still lacking of dose-response relationship of SND in cardiovascular disease at the metabolic level." | 1.46 | Serum metabolomics analysis reveals that obvious cardioprotective effects of low dose Sini decoction against isoproterenol-induced myocardial injury in rats. ( Chen, C; Chen, J; Li, F; Li, J; Ma, X; Shi, M; Sun, Y; Xiong, Y; Zhou, J, 2017) |
| "Post-isoproterenol treatment cardiac troponin I concentrations were greater in CD/IGS and Sasco rats compared with Harlan rats." | 1.37 | A comparison of mortality and cardiac biomarker response between three outbred stocks of Sprague Dawley rats treated with isoproterenol. ( Ackermann, BL; Hall, DG; Hoffman, WP; Lee, HY; Main, BW; Pritt, ML; Schultze, AE; Smith, HW, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (16.07) | 18.7374 |
| 1990's | 4 (7.14) | 18.2507 |
| 2000's | 6 (10.71) | 29.6817 |
| 2010's | 26 (46.43) | 24.3611 |
| 2020's | 11 (19.64) | 2.80 |
| Authors | Studies |
|---|---|
| Rhana, P | 1 |
| Barros, GM | 1 |
| Santos, VCO | 1 |
| Costa, AD | 1 |
| Santos, DMD | 1 |
| Fernandes-Braga, W | 1 |
| Durço, AO | 1 |
| Santos, MRV | 1 |
| Roman-Campos, D | 1 |
| Vasconcelos, CML | 1 |
| Cruz, JS | 1 |
| Souza, DS | 1 |
| Abedalqader, NN | 1 |
| Rababa'h, AM | 1 |
| Ababneh, M | 1 |
| Obeidat, HM | 1 |
| Althunibat, OY | 1 |
| Alfwuaires, MA | 1 |
| Aladaileh, SH | 1 |
| Algefare, AI | 1 |
| Almuqati, AF | 1 |
| Alasmari, F | 1 |
| Aldal'in, HK | 1 |
| Alanezi, AA | 1 |
| Alsuwayt, B | 1 |
| Abukhalil, MH | 1 |
| Bajic, Z | 1 |
| Sobot, T | 1 |
| Uletilovic, S | 1 |
| Mandic-Kovacevic, N | 1 |
| Cvjetkovic, T | 1 |
| Malicevic, U | 1 |
| Djukanovic, D | 1 |
| Duran, M | 1 |
| Vesic, N | 1 |
| Avram, S | 1 |
| Jovicic, S | 1 |
| Katana, M | 1 |
| Matavulj, A | 1 |
| Ponorac, N | 1 |
| Djuric, DM | 1 |
| Stojiljkovic, MP | 1 |
| Skrbić, R | 1 |
| Sharma, M | 1 |
| Singh, TU | 1 |
| Rana, A | 1 |
| Kumar, T | 1 |
| Gari, M | 1 |
| Mani, P | 1 |
| Lingaraju, MC | 1 |
| Parida, S | 1 |
| Singh, V | 1 |
| Sahoo, M | 1 |
| Kumar, D | 1 |
| Li, H | 1 |
| Shen, J | 1 |
| Zhang, Y | 3 |
| Hu, L | 1 |
| Luo, W | 1 |
| Refaie, MMM | 1 |
| Fouli Gaber Ibrahim, M | 1 |
| Fawzy, MA | 1 |
| Abdel-Hakeem, EA | 1 |
| Shaaban Mahmoud Abd El Rahman, E | 1 |
| Zenhom, NM | 1 |
| Shehata, S | 1 |
| Yokota, T | 1 |
| McCourt, J | 1 |
| Ma, F | 1 |
| Ren, S | 1 |
| Li, S | 1 |
| Kim, TH | 1 |
| Kurmangaliyev, YZ | 1 |
| Nasiri, R | 1 |
| Ahadian, S | 1 |
| Nguyen, T | 1 |
| Tan, XHM | 1 |
| Zhou, Y | 1 |
| Wu, R | 1 |
| Rodriguez, A | 1 |
| Cohn, W | 1 |
| Wang, Y | 1 |
| Whitelegge, J | 1 |
| Ryazantsev, S | 1 |
| Khademhosseini, A | 1 |
| Teitell, MA | 1 |
| Chiou, PY | 1 |
| Birk, DE | 1 |
| Rowat, AC | 1 |
| Crosbie, RH | 1 |
| Pellegrini, M | 1 |
| Seldin, M | 1 |
| Lusis, AJ | 1 |
| Deb, A | 1 |
| Hasan, R | 1 |
| Lasker, S | 1 |
| Hasan, A | 1 |
| Zerin, F | 1 |
| Zamila, M | 1 |
| Chowdhury, FI | 1 |
| Nayan, SI | 1 |
| Rahman, MM | 1 |
| Khan, F | 1 |
| Subhan, N | 1 |
| Alam, MA | 1 |
| Bun, SS | 1 |
| Taïeb, J | 1 |
| Scarlatti, D | 1 |
| Squara, F | 1 |
| Taghji, P | 1 |
| Errahmouni, A | 1 |
| Hasni, K | 1 |
| Enache, B | 1 |
| Amara, W | 1 |
| Deharo, JC | 1 |
| Ferrari, E | 1 |
| Maleki Dizaji, N | 1 |
| Garjani, A | 1 |
| Mousavi, S | 1 |
| Mohammadi, M | 1 |
| Vaez, H | 1 |
| Zhou, J | 1 |
| Ma, X | 1 |
| Shi, M | 1 |
| Chen, C | 1 |
| Sun, Y | 1 |
| Li, J | 1 |
| Xiong, Y | 1 |
| Chen, J | 1 |
| Li, F | 1 |
| Cheng, Y | 1 |
| Chao, J | 1 |
| Dai, D | 1 |
| Dai, Y | 1 |
| Zhu, D | 1 |
| Liu, B | 1 |
| Al-Rasheed, NM | 2 |
| Al-Rabeeah, DA | 1 |
| Al-Barrak, HS | 1 |
| Al-Salman, SA | 1 |
| Ibrahim, SA | 1 |
| Al-Hassab, SA | 1 |
| Al-Amin, MA | 1 |
| Hasan, IH | 1 |
| Al-Ajmi, HN | 1 |
| Al-Shammari, TK | 1 |
| Abd El-Fattah, AI | 1 |
| Zaghloul, MS | 1 |
| Eltablawy, NA | 1 |
| Rashed, LA | 1 |
| Godugu, C | 1 |
| Kumari, P | 1 |
| Khurana, A | 1 |
| Zhang, GG | 1 |
| Cai, HQ | 1 |
| Li, YH | 1 |
| Sui, YB | 1 |
| Zhang, JS | 1 |
| Chang, JR | 1 |
| Ning, M | 1 |
| Wu, Y | 1 |
| Tang, CS | 1 |
| Qi, YF | 1 |
| Yin, XH | 1 |
| Herrmann, JE | 1 |
| Heale, J | 1 |
| Bieraugel, M | 1 |
| Ramos, M | 1 |
| Fisher, RL | 1 |
| Vickers, AE | 1 |
| Hasić, S | 1 |
| Hadžović-Džuvo, A | 1 |
| Jadrić, R | 1 |
| Kiseljaković, E | 1 |
| Liu, N | 1 |
| Xing, R | 1 |
| Yang, C | 1 |
| Tian, A | 1 |
| Lv, Z | 1 |
| Sun, N | 1 |
| Gao, X | 1 |
| Li, Z | 1 |
| Chen, M | 1 |
| Wang, M | 2 |
| Yang, Q | 1 |
| Wang, Z | 1 |
| Zhu, Y | 1 |
| Wang, C | 1 |
| Jia, Y | 1 |
| Li, Y | 1 |
| Wen, A | 1 |
| Thompson, KL | 1 |
| Boitier, E | 1 |
| Chen, T | 1 |
| Couttet, P | 1 |
| Ellinger-Ziegelbauer, H | 1 |
| Goetschy, M | 1 |
| Guillemain, G | 1 |
| Kanki, M | 1 |
| Kelsall, J | 1 |
| Mariet, C | 1 |
| de La Moureyre-Spire, C | 1 |
| Mouritzen, P | 1 |
| Nassirpour, R | 1 |
| O'Lone, R | 1 |
| Pine, PS | 1 |
| Rosenzweig, BA | 1 |
| Sharapova, T | 1 |
| Smith, A | 1 |
| Uchiyama, H | 1 |
| Yan, J | 1 |
| Yuen, PS | 1 |
| Wolfinger, R | 1 |
| Wang, LS | 1 |
| Lee, CT | 1 |
| Su, WL | 1 |
| Huang, SC | 1 |
| Wang, SC | 1 |
| Ji, X | 1 |
| Takahashi, R | 1 |
| Hiura, Y | 1 |
| Hirokawa, G | 1 |
| Fukushima, Y | 1 |
| Iwai, N | 1 |
| Brooks, WW | 1 |
| Conrad, CH | 1 |
| Brady, S | 2 |
| York, M | 2 |
| Scudamore, C | 1 |
| Williams, T | 2 |
| Griffiths, W | 1 |
| Turton, J | 2 |
| Navarro-Sobrino, M | 1 |
| Lorita, J | 1 |
| Soley, M | 1 |
| Ramírez, I | 1 |
| George, JC | 1 |
| Liner, A | 1 |
| Hoit, BD | 1 |
| Wang, T | 1 |
| Yu, X | 1 |
| Qu, S | 1 |
| Xu, H | 1 |
| Han, B | 1 |
| Sui, D | 1 |
| Clements, P | 1 |
| Berridge, B | 1 |
| Mikaelian, I | 1 |
| Nicklaus, R | 1 |
| Gandhi, M | 1 |
| Roman, I | 1 |
| Stamp, C | 1 |
| Davies, D | 1 |
| McGill, P | 1 |
| Pettit, S | 1 |
| Walker, D | 1 |
| Schultze, AE | 1 |
| Main, BW | 1 |
| Hall, DG | 1 |
| Hoffman, WP | 1 |
| Lee, HY | 1 |
| Ackermann, BL | 1 |
| Pritt, ML | 1 |
| Smith, HW | 1 |
| Jimenez, SK | 1 |
| Jassal, DS | 1 |
| Kardami, E | 2 |
| Cattini, PA | 1 |
| Sojitra, B | 1 |
| Bulani, Y | 1 |
| Putcha, UK | 1 |
| Kanwal, A | 1 |
| Gupta, P | 1 |
| Kuncha, M | 1 |
| Banerjee, SK | 1 |
| Joukar, S | 3 |
| Najafipour, H | 1 |
| Dabiri, S | 2 |
| Sheibani, V | 1 |
| Esmaeili-Mahani, S | 1 |
| Ghotbi, P | 2 |
| Amanallahi, F | 1 |
| Joukar, F | 3 |
| Rémond, MC | 1 |
| Iaffaldano, G | 1 |
| O'Quinn, MP | 1 |
| Mezentseva, NV | 1 |
| Garcia, V | 1 |
| Harris, BS | 1 |
| Gourdie, RG | 1 |
| Eisenberg, CA | 1 |
| Eisenberg, LM | 1 |
| De, S | 1 |
| Adhikari, S | 1 |
| Devasagayam, TP | 1 |
| Bashiri, H | 1 |
| Sarveazad, A | 1 |
| Divsalar, K | 1 |
| Abbaszadeh, M | 1 |
| Chen, S | 1 |
| Du, J | 1 |
| Liang, Y | 1 |
| Zhang, R | 1 |
| Tang, C | 1 |
| Jin, H | 1 |
| Sheibani, M | 1 |
| Felten, ML | 1 |
| Cosson, C | 1 |
| Charpentier, J | 1 |
| Paradis, V | 1 |
| Benhamou, D | 1 |
| Mazoit, JX | 1 |
| Edouard, AR | 1 |
| Pasumarthi, KB | 1 |
| Nakajima, H | 1 |
| Nakajima, HO | 1 |
| Soonpaa, MH | 1 |
| Field, LJ | 1 |
| Chen, XJ | 1 |
| Meng, D | 1 |
| Feng, L | 1 |
| Bian, YY | 1 |
| Li, P | 1 |
| Yang, D | 1 |
| Cao, KJ | 1 |
| Zhang, JN | 1 |
| Loh, HK | 1 |
| Sahoo, KC | 1 |
| Kishore, K | 1 |
| Ray, R | 1 |
| Nag, TC | 1 |
| Kumari, S | 1 |
| Arya, DS | 1 |
| Viano, DC | 1 |
| Padua, RR | 1 |
| Nakatsuji, S | 1 |
| Yamate, J | 1 |
| Kuwamura, M | 1 |
| Kotani, T | 1 |
| Sakuma, S | 1 |
| Miyazato, H | 1 |
| Biro, S | 1 |
| Setoguchi, M | 1 |
| Maeda, M | 1 |
| Tashiro, T | 1 |
| Nakao, S | 1 |
| Tanaka, H | 1 |
| Xia, ZF | 1 |
| Horton, JW | 1 |
| Zhao, P | 1 |
| Lin, C | 1 |
| Sherry, AD | 1 |
| Malloy, CR | 1 |
| Faltová, E | 1 |
| Mráz, M | 1 |
| Parízková, J | 1 |
| Sedivý, J | 1 |
| Kim, HD | 1 |
| Rah, BJ | 1 |
| Judd, JT | 1 |
| Wexler, BC | 1 |
| Deiraniya, AK | 1 |
| Shoemaker, WC | 1 |
| Carey, JS | 1 |
| Yao, ST | 1 |
| Mohr, PA | 1 |
| Printen, KJ | 1 |
| Kark, AE | 1 |
| Rosen, KM | 1 |
| Heller, R | 1 |
| Ehsani, A | 1 |
| Rahimtoola, SH | 1 |
| MacCannell, KL | 1 |
| Arrigoni, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Feasibility Study of Circulating microRNAs as Disease Markers in Pediatric Cancers[NCT01541800] | 20 participants (Anticipated) | Observational | 2010-03-31 | Recruiting | |||
| A Longitudinal Study of Biomarkers in Pediatric Patients With Central Nervous System Tumors[NCT01595126] | 100 participants (Anticipated) | Observational | 2011-12-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
56 other studies available for isoproterenol and Cardiac Rupture, Traumatic
| Article | Year |
|---|---|
S-limonene protects the heart in an experimental model of myocardial infarction induced by isoproterenol: Possible involvement of mitochondrial reactive oxygen species.
Topics: Animals; Antioxidants; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Heart Injuries; Isoproter | 2022 |
The protective effect of rivaroxaban with or without aspirin on inflammation, oxidative stress, and platelet reactivity in isoproterenol-induced cardiac injury in rats.
Topics: Animals; Aspirin; Biomarkers; Factor Xa Inhibitors; Heart Injuries; Inflammation; Isoproterenol; Mal | 2023 |
Cardioprotective Effect of Taxifolin against Isoproterenol-Induced Cardiac Injury through Decreasing Oxidative Stress, Inflammation, and Cell Death, and Activating Nrf2/HO-1 in Mice.
Topics: Antioxidants; Apoptosis; Heart Injuries; Humans; Inflammation; Isoproterenol; NF-E2-Related Factor 2 | 2022 |
Cardioprotective effects of liraglutide pretreatment on isoprenaline-induced myocardial injury in rats.
Topics: Animals; Antioxidants; Diabetes Mellitus, Type 2; Glucagon-Like Peptide-1 Receptor; Heart Injuries; | 2023 |
Biochanin-A alleviates fibrosis and inflammation in cardiac injury in mice.
Topics: Animals; Collagen; Collagen Type I; Fibrosis; Heart Injuries; Inflammation; Isoproterenol; Lipids; M | 2023 |
6-Shogaol protects against isoproterenol-induced cardiac injury in rats through attenutating oxidative stress, inflammation, apoptosis and activating nuclear respiratory factor-2/heme oxygenase-1 signaling pathway.
Topics: Animals; Antioxidants; Apoptosis; Catechols; Creatine Kinase; GA-Binding Protein Transcription Facto | 2022 |
Molecular mechanisms mediate roflumilast protective effect against isoprenaline-induced myocardial injury.
Topics: Animals; Antioxidants; Heart Injuries; Isoproterenol; Myocardium; Oxidative Stress; Rats; Rats, Wist | 2023 |
Type V Collagen in Scar Tissue Regulates the Size of Scar after Heart Injury.
Topics: Animals; Cicatrix; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type III; Collagen Type | 2020 |
Canagliflozin attenuates isoprenaline-induced cardiac oxidative stress by stimulating multiple antioxidant and anti-inflammatory signaling pathways.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Canagliflozin; Disease Models, Animal; H | 2020 |
[Organization and management of acute complete atrioventricular block: Results from a Multicenter National Survey].
Topics: Adult; After-Hours Care; Aged; Algeria; Atrioventricular Block; Cardiotonic Agents; Drug Resistance; | 2021 |
Time-dependent influence of infliximab on hemodynamic responses and cardiac injuries of isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Body Weight; Disease Models, Animal; Heart Injuries | 2021 |
Serum metabolomics analysis reveals that obvious cardioprotective effects of low dose Sini decoction against isoproterenol-induced myocardial injury in rats.
Topics: Animals; Biomarkers; Cardiotonic Agents; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; En | 2017 |
AQP4-knockout aggravation of isoprenaline-induced myocardial injury is mediated by p66Shc and endoplasmic reticulum stress.
Topics: Animals; Aquaporin 4; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Gene Knocko | 2017 |
Possible protective mechanisms exerted by metformin or metformin and vitamin E in isoproterenol-induced cardiac injury.
Topics: Animals; Heart Injuries; Isoproterenol; Male; Metformin; NF-kappa B; Rats; Rats, Wistar; Signal Tran | 2018 |
α-Lipoic acid and amlodipine/perindopril combination potentiate the therapeutic effect of mesenchymal stem cells on isoproterenol induced cardiac injury in rats.
Topics: Amlodipine; Animals; Drug Therapy, Combination; Heart Injuries; Isoproterenol; Male; Mesenchymal Ste | 2019 |
Nanoyttria attenuates isoproterenol-induced cardiac injury.
Topics: Animals; Cardiotoxicity; Cytokines; Gene Expression Regulation; Heart; Heart Injuries; Hydroxyprolin | 2018 |
Ghrelin protects heart against ERS-induced injury and apoptosis by activating AMP-activated protein kinase.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Cardiotonic Agents; Cells, Cultured; Endoplasmic | 2013 |
Isoproterenol effects evaluated in heart slices of human and rat in comparison to rat heart in vivo.
Topics: Aged; Animals; Antigens, Neoplasm; Apoptosis; Biomarkers, Tumor; Chemokine CCL7; Female; Fibrosis; H | 2014 |
B-type natriuretic peptide and adiponectin releases in rat model of myocardial damage induced by isoproterenol administration.
Topics: Adiponectin; Animals; Biomarkers; Disease Models, Animal; Heart Injuries; Isoproterenol; Male; Myoca | 2013 |
HIP-55/DBNL-dependent regulation of adrenergic receptor mediates the ERK1/2 proliferative pathway.
Topics: Animals; Animals, Newborn; Cell Proliferation; Cells, Cultured; Fibroblasts; Fibrosis; Gene Expressi | 2014 |
Antioxidant effects of hydroxysafflor yellow A and acetyl-11-keto-β-boswellic acid in combination on isoproterenol-induced myocardial injury in rats.
Topics: Animals; Antioxidants; Cardiotonic Agents; Cell Hypoxia; Chalcone; Creatine Kinase, MB Form; Drug Co | 2016 |
Absolute Measurement of Cardiac Injury-Induced microRNAs in Biofluids across Multiple Test Sites.
Topics: Animals; Biomarkers; Heart Injuries; Isoproterenol; Male; MicroRNAs; Plasma; Rats; Rats, Wistar; Rea | 2016 |
Delonix regia Leaf Extract (DRLE): A Potential Therapeutic Agent for Cardioprotection.
Topics: Animals; Cardiomegaly; Cardiotonic Agents; Creatine Kinase; Fabaceae; Female; Heart; Heart Injuries; | 2016 |
Plasma miR-208 as a biomarker of myocardial injury.
Topics: Animals; Aspartate Aminotransferases; Cardiomegaly; Heart Injuries; Isoproterenol; Kidney; Male; Mic | 2009 |
Plasma miR-208 as a biomarker of myocardial injury.
Topics: Animals; Aspartate Aminotransferases; Cardiomegaly; Heart Injuries; Isoproterenol; Kidney; Male; Mic | 2009 |
Plasma miR-208 as a biomarker of myocardial injury.
Topics: Animals; Aspartate Aminotransferases; Cardiomegaly; Heart Injuries; Isoproterenol; Kidney; Male; Mic | 2009 |
Plasma miR-208 as a biomarker of myocardial injury.
Topics: Animals; Aspartate Aminotransferases; Cardiomegaly; Heart Injuries; Isoproterenol; Kidney; Male; Mic | 2009 |
Isoproterenol-induced myocardial injury and diastolic dysfunction in mice: structural and functional correlates.
Topics: Adrenergic beta-Agonists; Animals; Heart Injuries; Isoproterenol; Male; Mice | 2009 |
Cardiac troponin I in isoproterenol-induced cardiac injury in the Hanover Wistar rat: studies on low dose levels and routes of administration.
Topics: Animals; Biomarkers; Dose-Response Relationship, Drug; Female; Heart Injuries; Injections, Intraperi | 2010 |
Catecholamine-induced heart injury in mice: differential effects of isoproterenol and phenylephrine.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Cardiotonic Agents; Catecholamines; Ep | 2010 |
Isoproterenol-induced myocardial injury: a systematic comparison of subcutaneous versus intraperitoneal delivery in a rat model.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Female; Heart Injuries; Humans; Injections, Int | 2010 |
Effect of ginsenoside Rb3 on myocardial injury and heart function impairment induced by isoproterenol in rats.
Topics: Animals; Cardiomyopathies; Catalase; Creatine Kinase; Ginsenosides; Heart; Heart Injuries; Heart Ven | 2010 |
Time course characterization of serum cardiac troponins, heart fatty acid-binding protein, and morphologic findings with isoproterenol-induced myocardial injury in the rat.
Topics: Animals; Biomarkers; Cardiotonic Agents; Fatty Acid-Binding Proteins; Heart; Heart Injuries; Immunoa | 2010 |
A comparison of mortality and cardiac biomarker response between three outbred stocks of Sprague Dawley rats treated with isoproterenol.
Topics: Animals; Biomarkers; Dose-Response Relationship, Drug; Fatty Acid Binding Protein 3; Fatty Acid-Bind | 2011 |
A single bout of exercise promotes sustained left ventricular function improvement after isoproterenol-induced injury in mice.
Topics: Animals; Echocardiography, Doppler; Female; Heart; Heart Injuries; Isoproterenol; Male; Mice; Mice, | 2011 |
Nitric oxide synthase inhibition abrogates hydrogen sulfide-induced cardioprotection in mice.
Topics: Animals; Biomarkers; Cardiotonic Agents; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; G | 2012 |
The effect of chronic co-administration of morphine and verapamil on isoproterenol-induced heart injury.
Topics: Animals; Calcium Channel Blockers; Cardiotonic Agents; Drug Synergism; Heart; Heart Injuries; Isopro | 2011 |
GATA6 reporter gene reveals myocardial phenotypic heterogeneity that is related to variations in gap junction coupling.
Topics: Adherens Junctions; Animals; beta-Galactosidase; Cardiomegaly; Cell Communication; Cells, Cultured; | 2011 |
Cardioprotective effects of an aminothiazole compound on isoproterenol-induced myocardial injury in mice.
Topics: Animals; Antioxidants; Biomarkers; Cardiotonic Agents; Dose-Response Relationship, Drug; Heart Injur | 2013 |
Cardiovascular effects of black tea and nicotine alone or in combination against experimental induced heart injury.
Topics: Blood Pressure; Camellia sinensis; Cardiotonic Agents; Drug Synergism; Drug Therapy, Combination; He | 2012 |
Sulfur dioxide restores calcium homeostasis disturbance in rat with isoproterenol-induced myocardial injury.
Topics: Animals; Blotting, Western; Calcium; Cardiotonic Agents; Disease Models, Animal; Heart Diseases; Hea | 2012 |
Cardiovascular effect of nifedipine in morphine dependent rats: hemodynamic, histopathological, and biochemical evidence.
Topics: Analgesics, Opioid; Animals; Blood Pressure; Calcium Channel Blockers; Dimethyl Sulfoxide; Heart Inj | 2012 |
Effect of isoproterenol on the cardiac troponin I degradation and release during early TNFalpha-induced ventricular dysfunction in isolated rabbit heart.
Topics: Animals; Dose-Response Relationship, Drug; Drug Administration Schedule; France; Heart Injuries; Hum | 2004 |
Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice.
Topics: Age Factors; Animals; Animals, Newborn; Cardiomegaly; Coronary Disease; Cyclin D1; Cyclin D2; Cyclin | 2005 |
Protective effect of astragalosides on myocardial injury by isoproterenol in SD rats.
Topics: Adenosine Triphosphate; Animals; Astragalus propinquus; Calcium; Cardiotonic Agents; Drugs, Chinese | 2006 |
Effects of thalidomide on isoprenaline-induced acute myocardial injury: a haemodynamic, histopathological and ultrastructural study.
Topics: Administration, Oral; Animals; Blood Pressure; Dose-Response Relationship, Drug; Endocardium; Heart; | 2007 |
Cardiovascular injury from blunt thoracic impact of epinephrine and isoproterenol injected rabbits.
Topics: Animals; Blood Pressure; Epinephrine; Heart Injuries; Heart Ventricles; Hypertension; Hypotension; I | 1983 |
Increased basic fibroblast growth factor (bFGF) accumulation and distinct patterns of localization in isoproterenol-induced cardiomyocyte injury.
Topics: Animals; Desmin; Fibroblast Growth Factor 2; Gene Expression; Heart Injuries; Immunohistochemistry; | 1993 |
In vivo responses of macrophages and myofibroblasts in the healing following isoproterenol-induced myocardial injury in rats.
Topics: Animals; Fibroblasts; Heart; Heart Injuries; Immunohistochemistry; Isoproterenol; Macrophages; Male; | 1997 |
Abnormal immunostaining for dystrophin in isoproterenol-induced acute myocardial injury in rats: evidence for change in dystrophin in the absence of genetic defect.
Topics: Actins; Animals; Cardiotonic Agents; Cytoplasm; Dystrophin; Edema; Eosine Yellowish-(YS); Heart Dise | 1997 |
Relationship between energetic, ionic, and functional status in the perfused rat heart following thermal injury: a 31P and 23Na NMR study.
Topics: Adrenergic beta-Agonists; Animals; Burns; Calcium; Energy Metabolism; Heart; Heart Injuries; In Vitr | 1997 |
Physical activity of different intensities and the development of myocardial resistance to injury.
Topics: Age Factors; Animals; Heart Injuries; Isoproterenol; Male; Motor Activity; Physical Exertion; Rats; | 1985 |
Effects of diltiazem on isoproterenol- or Ca-induced ventricular myocardial cell injuries in isolated perfused rabbit heart: an electron microscopic study.
Topics: Animals; Calcium; Diltiazem; Female; Heart; Heart Injuries; Heart Ventricles; Isoproterenol; Male; M | 1988 |
Myocardial connective tissue metabolism in response to injury. II. Investigation of the mucopolysaccharides involved in isoproterenol-induced necrosis and repair in rat hearts.
Topics: Amino Sugars; Animals; Chondroitin; Cicatrix; Connective Tissue; Edema; Glycoproteins; Glycosaminogl | 1970 |
Cardiac herniation following intrapericardial pneumonectomy.
Topics: Aged; Bradycardia; Bronchopneumonia; Cyanosis; Electrocardiography; Female; Heart Block; Heart Injur | 1974 |
Hemodynamic monitoring for physiologic evaluation, diagnosis, and therapy of acute hemopericardial tamponade from penetrating wounds.
Topics: Blood Pressure; Cardiac Output; Cardiac Tamponade; Central Venous Pressure; Dextrans; Heart Injuries | 1973 |
Localization of site of traumatic heart block with His bundle recordings: electrophysiologic observations regarding the nature of "split" H potentials.
Topics: Adult; Atropine; Bundle-Branch Block; Cardiac Catheterization; Electrocardiography; Electrophysiolog | 1972 |
Hemodynamic responses to dopamine and to isoproterenol following acute myocardial injury.
Topics: Animals; Arrhythmias, Cardiac; Blood Flow Velocity; Blood Pressure; Cardiac Output; Dogs; Dopamine; | 1969 |
[Effects of a nitroderivative on myocardial lesions produced by isoproterenol in rats].
Topics: Animals; Ethylenediamines; Heart Injuries; Isoproterenol; Male; Rats; Vasodilator Agents | 1969 |